title: Bacillary angiomatosis in HIV-infected patients--an epidemiological and clinical study.
abstract: BACKGROUND
  No data were available on the epidemiological and clinical characteristics of bacillary angiomatosis (BA) in Germany.
  
  
  OBJECTIVE
  To determine epidemiological and clinical data on HIV-associated BA.
  
  
  METHODS
  A chart review of all BA cases between 1990 and 1998 was performed in 23 German AIDS treatment units.
  
  
  RESULTS
  A total of 21 cases of BA was diagnosed. During this period, the participating HIV centers treated about 17,000 HIV-infected patients. As a result, a BA prevalence of 1.2 cases/1,000 patients can be assumed. 19 BA were localized in the skin; in 5 cases bones and in 4 cases the liver were involved. Out of 20 patients who received antibiotic therapy, 13 had complete remission. The median time of duration up to complete remission was 32 days (9-82). During the follow-up of the 20 patients, 7 relapses were observed.
  
  
  CONCLUSIONS
  BA is a rare HIV-associated disease with a prevalence of 1,2 cases/1,000 patients in the presented study.
authors.affiliation: Allgemeines Krankenhaus St. Georg, Hamburg, Deutschland. Plettenberg@compuserve.com
authors.forename: A
authors.initials: A
authors.lastname: Plettenberg
authors.forename: T
authors.initials: T
authors.lastname: Lorenzen
authors.forename: B T
authors.initials: BT
authors.lastname: Burtsche
authors.forename: H
authors.initials: H
authors.lastname: Rasokat
authors.forename: T
authors.initials: T
authors.lastname: Kaliebe
authors.forename: H
authors.initials: H
authors.lastname: Albrecht
authors.forename: T
authors.initials: T
authors.lastname: Mertenskötter
authors.forename: J R
authors.initials: JR
authors.lastname: Bogner
authors.forename: A
authors.initials: A
authors.lastname: Stoehr
authors.forename: H
authors.initials: H
authors.lastname: Schöfer
mesh_terms: D000328:Adult; D000368:Aged; D016917:Angiomatosis, Bacillary / Q000188:drug therapy / Q000453:epidemiology / Q000473:pathology*; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D001473:Bartonella / Q000187:drug effects / Q000648:ultrastructure; D018791:CD4 Lymphocyte Count; D004917:Erythromycin / Q000627:therapeutic use; D005260:Female; D005858:Germany / Q000453:epidemiology; D015658:HIV Infections / Q000150:complications*; D006801:Humans; D008297:Male; D008854:Microscopy, Electron; D008875:Middle Aged; D015995:Prevalence; D012189:Retrospective Studies; D016019:Survival Analysis
chemical_list: D000900:Anti-Bacterial Agents; D004917:Erythromycin